The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Amgen
Patents, Royalties, Other Intellectual Property - TLR4 Inhibitor / IP

A single arm phase 2 study of talimogene laherparepvec in patients with low-risk invasive cutaneous squamous cell cancer. interim analysis.
 
Clara N Curiel
No Relationships to Disclose
 
Delaney Stratton
No Relationships to Disclose
 
Haiyan Cui
No Relationships to Disclose
 
Denise Roe
No Relationships to Disclose
 
Hina Arif Tiwari
No Relationships to Disclose
 
Srinath Sundararajan
No Relationships to Disclose